| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,527 |
3,390 |
$374K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,763 |
2,749 |
$217K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,582 |
1,576 |
$192K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,378 |
3,214 |
$176K |
| 99051 |
|
2,914 |
2,843 |
$38K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,007 |
991 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
298 |
149 |
$4K |
| 87428 |
|
25 |
25 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
64 |
64 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
98 |
82 |
$1K |
| 99215 |
Prolong outpt/office vis |
13 |
13 |
$1K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
216 |
207 |
$630.65 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
32 |
31 |
$323.50 |
| 81003 |
|
12 |
12 |
$23.76 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
26 |
24 |
$3.90 |
| 99072 |
|
35 |
32 |
$0.00 |